We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

155 hedge funds and large institutions have $418M invested in Niagen Bioscience in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 25

143% more capital invested

Capital invested by funds: $172M → $418M (+$246M)

81% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 21

12% more funds holding

Funds holding: 139 → 155 (+16)

10% more call options, than puts

Call options by funds: $3.47M | Put options by funds: $3.14M

4.82% more ownership

Funds ownership: 32.02% → 36.84% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
155
Holders Change
+16
Holders Change %
+11.51%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
74
Reduced
25
Closed
21
Calls
$3.47M
Puts
$3.14M
Net Calls
+$323K
Net Calls Change
-$1.42M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$8.29M
2
WCM
Woodson Capital Management
Connecticut
+$4.94M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.79M
5
Morgan Stanley
Morgan Stanley
New York
+$3.37M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.73M
2
IC
Iconiq Capital
California
-$4.04M
3
TCM
Tieton Capital Management
Washington
-$4M
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$2.1M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$3.23M -$709K -71,844 -24%
Lazard Asset Management
27
Lazard Asset Management
New York
$3.12M +$122K +12,314 +6%
GF
28
Gabelli Funds
New York
$2.74M -$147K -14,900 -7%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.66M +$110K +11,146 +6%
Goldman Sachs
30
Goldman Sachs
New York
$2.61M -$849K -85,987 -32%
Marshall Wace
31
Marshall Wace
United Kingdom
$2.34M -$1.35M -136,844 -46%
Tudor Investment Corp
32
Tudor Investment Corp
Connecticut
$2.3M -$2.1M -212,250 -57%
Charles Schwab
33
Charles Schwab
California
$2.25M +$114K +11,499 +8%
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$2.22M -$60K -6,072 -4%
NA
35
Navellier & Associates
Nevada
$2.19M +$267K +27,015 +22%
TI
36
Trexquant Investment
Connecticut
$1.93M -$749K -75,899 -36%
Prudential Financial
37
Prudential Financial
New Jersey
$1.93M +$380K +38,461 +40%
GI
38
GAMCO Investors
Connecticut
$1.86M -$138K -14,000 -10%
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$1.8M – – –
AG
40
Algert Global
California
$1.8M +$518K +52,430 +73%
Millennium Management
41
Millennium Management
New York
$1.75M -$4.73M -479,347 -80%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$1.56M +$398K +40,279 +59%
CCIA
43
Campbell & Co Investment Adviser
Maryland
$1.5M +$1.03M +104,431 New
PWS
44
Precision Wealth Strategies
Missouri
$1.48M +$1.01M +102,364 New
SBCM
45
Silverberg Bernstein Capital Management
New York
$1.43M +$38.9K +3,939 +4%
American Century Companies
46
American Century Companies
Missouri
$1.38M +$750K +75,993 +386%
Barclays
47
Barclays
United Kingdom
$1.37M +$407K +41,256 +77%
BCM
48
Bridgeway Capital Management
Texas
$1.33M +$910K +92,179 New
SSA
49
Sierra Summit Advisors
Nevada
$1.3M +$894K +90,511 New
UBS Group
50
UBS Group
Switzerland
$1.23M +$301K +30,520 +55%
1
2
3 4 5

NAGE Hedge Fund Activity: Q2 2025 in Review

155 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2025, worth a combined $418M — up 143% from $172M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new NAGE positions and 21 closed out — a net gain of 17 holders — while 74 added to existing stakes and 25 trimmed.

The largest buyer was Nuveen, adding an estimated $8.29M. The largest seller was Millennium Management, cutting an estimated $4.73M.

  • 155 institutional investors held Niagen Bioscience (NAGE) as of Q2 2025, up from 139 in Q1 2025.
  • Funds reported $418M of Niagen Bioscience stock for Q2 2025, up 143% quarter-over-quarter.
  • 38 funds opened new Niagen Bioscience positions in Q2 2025 and 21 closed out, a net change of +17 holders.
  • The largest Niagen Bioscience buyer in Q2 2025 was Nuveen, an estimated $8.29M added.
  • The largest Niagen Bioscience seller in Q2 2025 was Millennium Management, an estimated $4.73M sold.

Based on aggregated 13F filings for Q2 2025.